Merrion H1 profits down despite revenue increase
ISEQ-quoted Merrion Pharmaceuticals today reported a net loss of €2.3m for the six months to end June, compared to a loss of €2.1m for H1 2008.
The decrease came despite a 378% increase in revenues to €1.7m from €354,000 in the same period of the previous year.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





